Cargando…
No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
PURPOSE: To assess whether dysglycemia diagnosed during severe acute respiratory syndrome coronavirus 2 pneumonia may become a potential public health problem after resolution of the infection. In an adult cohort with suspected coronavirus disease 2019 (COVID-19) pneumonia, we integrated glucose dat...
Autores principales: | Laurenzi, Andrea, Caretto, Amelia, Molinari, Chiara, Mercalli, Alessia, Melzi, Raffaella, Nano, Rita, Tresoldi, Cristina, Rovere Querini, Patrizia, Ciceri, Fabio, Lampasona, Vito, Bosi, Emanuele, Scavini, Marina, Piemonti, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691144/ https://www.ncbi.nlm.nih.gov/pubmed/34718627 http://dx.doi.org/10.1210/clinem/dgab792 |
Ejemplares similares
-
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
por: Laurenzi, Andrea, et al.
Publicado: (2021) -
Dysglycemia after COVID-19 pneumonia: a six-month cohort study
por: Molinari, Chiara, et al.
Publicado: (2021) -
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
por: Lampasona, Vito, et al.
Publicado: (2020) -
Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
por: Piemonti, Lorenzo, et al.
Publicado: (2013) -
Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
por: Bolla, Andrea Mario, et al.
Publicado: (2019)